Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation
Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S0898656826006558?dgcid=rss_sd_all
Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S0898656826006558?dgcid=rss_sd_all
“Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation.” Cellular Signalling.
@article{article99867,
title = {Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S0898656826006558?dgcid=rss_sd_all}
}